Citation: | HUANG Xiaoqin, YU Yanmin, LU Xiaofan, ZHANG Heqin. Effect of ADOPT nursing mode combined with group intervention in patients with nasopharyngeal carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 97-100. DOI: 10.7619/jcmp.20202003 |
[1] |
于彩艳, 周明辉, 管树荣. 鼻咽癌放疗患者应用中医综合护理干预对口咽部真菌感染的临床效果[J]. 国际护理学杂志, 2019, 38(4): 522-525. doi: 10.3760/cma.j.issn.1673-4351.2019.04.029
|
[2] |
李洁霞, 韦萍, 黄连云, 等. 系统性康复干预在鼻咽癌放疗后吞咽困难护理中的应用效果[J]. 中华现代护理杂志, 2017, 23(4): 482-486. doi: 10.3760/cma.j.issn.1674-2907.2017.04.009
|
[3] |
黄小梅, 赵娟, 刘联斌, 等. 综合性心理干预对鼻咽癌患者免疫功能的影响[J]. 中国实用护理杂志, 2017, 33(32): 2488-2492. doi: 10.3760/cma.j.issn.1672-7088.2017.32.002
|
[4] |
SOMMAT K, ONG W S, HUSSAIN A, et al. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma[J]. Int J Radiat Oncol Biol Phys, 2017, 98(3): 574-580. doi: 10.1016/j.ijrobp.2017.03.007
|
[5] |
SI J Y, WENG J J, ZHANG B J, et al. Diagnostic value of narrow-band imaging in detection of recurrent nasopharyngeal carcinoma[J]. Chinese journal of otorhinolaryngology head and neck surgery, 2017, 52(12): 895-899. http://europepmc.org/abstract/MED/29262446
|
[6] |
XIE X C, ZENG X C, CAO S J, et al. Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma[J]. Oncotarget, 2017, 8(62): 106089-106097. doi: 10.18632/oncotarget.22528
|
[7] |
LI B B, HUANG G L, LI H H, et al. Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells[J]. Chinese medical journal, 2017, 130(1): 93-99. doi: 10.4103/0366-6999.196586
|
[8] |
LONG M, FU Z, LI P, et al. Cigarette smoking and the risk of nasopharyngeal carcinoma: A meta-analysis of epidemiological studies[J]. BMJ Open, 2017, 7(10): e016582. doi: 10.1136/bmjopen-2017-016582
|
[9] |
ZHANG L, MACISAAC K D, ZHOU T, et al. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes[J]. Molecular Cancer Research Mcr, 2017, 15(12): 1722. doi: 10.1158/1541-7786.MCR-17-0134
|
[10] |
KE L, ZHOU H, WANG C, et al. Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis[J]. Proceedings of the National Academy of Sciences, 2017, 114(36): 201705236. http://europepmc.org/abstract/MED/28831010
|
[11] |
HALESHAPPA R A, THANKY A H, KUNTEGOWDANAHALLI L, et al. Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India[J]. South Asian Journal of Cancer, 2017, 6(3): 122. doi: 10.4103/2278-330x.214578
|
[12] |
GURTSEVITCH V E, SENYUTA N B, IGNATOVA A V, et al. Epstein-Barr virus biomarkers for nasopharyngeal carcinoma in non-endemic regions[J]. Journal of General Virology, 2017, 98(8): 2118-2127. doi: 10.1099/jgv.0.000889
|
[13] |
ZHAO S, ZHANG Y, LIANG X, et al. Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma[J]. Anti-cancer agents in medicinal chemistry, 2019, 19(6): 772. doi: 10.2174/1871520619666190204094815
|
[14] |
YANG H, ZHANG G, CHE X, et al. Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1[J]. Experimental and therapeutic medicine, 2018, 15(4): 3477-3482. http://europepmc.org/abstract/MED/29545871
|
[15] |
CHEN R, WANG Z, LAN R, et al. Influence of POLG on Radiosensitivity of Nasopharyngeal Carcinoma Cells[J]. Cancer Biotherapy and Radiopharmaceuticals, 2018, 33(4): 146-154. doi: 10.1089/cbr.2017.2346
|